Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Financial Results

Every financial results filing by a US-listed company that our alert engine sent, newest first.

4:16 PM ET 8-K
Financial Results Precipio, Inc. PRPO

Precipio Financial Results

Precipio reported record quarterly revenue of $7.3 million for Q3 2026, driven by growth in both its pathology and product segments. The company achieved positive Adjusted EBITDA of $0.4 million and generated $0.6 million in cash flow from operations, ending the period with a cash balance of $3.5 million.

Term
Q3 2026

“In the third quarter we continued to strengthen our financial position, delivering record revenue while maintaining positive Adjusted EBITDA and generating cash from operations.”

Ilan Danieli, CEO of Precipio

“Our pathology business continues to provide a strong operational and financial foundation for growth, while also serving as the clinical development and validation platform for our proprietary diagnostic products.”

Ilan Danieli, CEO of Precipio
4:16 PM ET 10-Q
Financial Results Energy Transition Special Opportunities ETSS

Energy Transition Special Opportunities Q3 2026 Results: Turns Profitable, Net Income $1.08M

Energy Transition Special Opportunities reported a net income of $1,080,025 for the quarter ended September 30, 2026, primarily driven by $1,383,203 in interest earned on investments held in the Trust Account. The company completed its initial public offering in May 2026, resulting in $152,761,728 held in trust and 15,000,000 Class A ordinary shares subject to possible redemption.

Key figure
Net income $1.08M
4:15 PM ET 8-K
Financial Results BrightView Holdings, Inc. BV

BrightView Holdings Financial Results

BrightView reported fiscal year 2026 results with total revenue of $2.71 billion, driven by 6% growth in Maintenance Services. The company introduced fiscal 2027 guidance expecting Land Maintenance revenue growth of 3-4% and Adjusted EBITDA between $335 million and $355 million. Management highlighted three consecutive quarters of Land Maintenance growth despite macroeconomic softness in the Development Services segment.

Term
FY2026

“We closed fiscal 2026 with our third consecutive quarter of Land Maintenance revenue growth. The underlying growth rate accelerated each quarter, reaching 3.3% in the fourth quarter, as improved customer retention and continued investment in our salesforce supported momentum in this highly recurring and predictable segment.”

Dale Asplund, BrightView President and Chief Executive Officer
4:15 PM ET 8-K
Financial Results RideNow Group, Inc. RDNW

RideNow Group Financial Results

RideNow Group reported third quarter 2026 revenue of $244.3 million, a 13.1% decrease year-over-year, driven by lower unit volumes and the implementation of a new transparent pricing model. The company reported a net loss of $13.9 million but successfully refinanced its senior secured term loan facility with a new $220 million loan maturing in 2031.

Term
Q3 2026

“The contraction we saw in the third quarter was primarily driven by our proactive, company-wide rollout of the 'RideNow Clear Price' strategy, designed to fully comply with FTC pricing guidelines. While the August rollout impacted our retail volume against non-compliant competitors during the quarter, we believe it is the right move to build long-term customer trust and position us as the dealership group of choice.”

Michael Quartieri, Chairman, Chief Executive Officer and President

“Ultimately, the structural changes and cost reductions we are implementing, coupled with accretive acquisitions, set us up very well to capture substantial operating leverage when the broader powersports cycle rebounds.”

Michael Quartieri, Chairman, Chief Executive Officer and President
4:15 PM ET 10-Q
Financial Results CitroTech Inc. CITR

CitroTech Q3 2026 Results: Net Loss of $2.28M, Loss Narrows

CitroTech Inc. reported a net loss of $12.39 million for the nine months ended September 30, 2026, an improvement from the $30.74 million loss in the prior year period. Total assets decreased significantly from $14.18 million at year-end 2025 to $8.55 million, primarily driven by a reduction in cash reserves used to fund operations.

Key figure
Net loss $2.28M
4:14 PM ET 10-Q
Financial Results First Community Corp FCCO

First Community Q3 2026 Results: Net Income $8.04M, Up 54.9% YoY

First Community Corp reported a significant increase in net income to $21.1 million for the first nine months of 2026, up from $14.4 million in 2025, driven by higher interest income on loans. Total assets grew to $2.36 billion following an acquisition that added $49.7 million in common stock consideration and increased goodwill to $29.4 million.

Key figure
Net income $8.04M · +54.9% YoY
4:14 PM ET 10-Q
Financial Results New Mountain Guardian IV BDC, L.L.C.

New Mountain Guardian IV BDC Q3 2026 Results: Net Income $22.1M, Up 9.8% YoY

For the nine months ended September 30, 2026, New Mountain Guardian IV BDC reported total investment income of $149.2 million and net investment income of $80.5 million. The company experienced a net decrease in members' capital resulting from operations of $49.8 million, primarily driven by $29.0 million in unrealized depreciation on investments. Total assets stood at $2.19 billion with a net asset value per unit of $9.73.

Key figure
Net income $22.1M · +9.8% YoY
4:14 PM ET 10-Q
Financial Results Silicon Laboratories Inc. SLAB

Silicon Laboratories Q3 2026 Results: Turns Profitable, Net Income $8.85M

Silicon Laboratories reported a return to profitability in the third quarter of 2026 with net income of $8.9 million, compared to a net loss of $9.9 million in the prior year period. However, for the nine months ended October 3, 2026, the company remains in a net loss position of $17.6 million as revenues grew to $692.6 million from $576.6 million year-over-year.

Key figure
Net income $8.85M
4:14 PM ET 8-K
Financial Results Satellogic Inc. SATL

Satellogic Financial Results

Satellogic reported record third-quarter revenue of $16.0 million, a 342% increase year-over-year, and its second consecutive quarter of positive Adjusted EBITDA. The company highlighted significant commercial momentum in its Space Systems segment, including a post-quarter agreement to sell three in-orbit satellites for approximately $37 million. Operational milestones included the October launch of Merlin.01 and new Mark VI satellites equipped with inter-satellite links to advance its Persistent Global Intelligence strategy.

Term
Q3 2026

“We delivered an excellent third quarter, with record revenue and our second consecutive quarter of positive Adjusted EBITDA. Revenue grew 342% year-over-year to $16.0 million, following $15.9 million in the second quarter, as we continued to execute across both Data & Analytics and Space Systems.”

Emiliano Kargieman, Satellogic Founder and CEO
4:13 PM ET 10-Q
Financial Results Vroom, Inc. VRM

Vroom Q3 2026 Results: Net Loss of $9.85M, Loss Narrows

Vroom, Inc. reported a significant increase in cash and cash equivalents to $33.0 million as of September 30, 2026, compared to $10.4 million at the end of 2025. The company has emerged from a Prepackaged Chapter 11 Case and completed its Ecommerce Wind-Down, shifting focus to its UACC and CarStory businesses under a Long-Term Strategic Plan.

Key figure
Net loss $9.85M
4:13 PM ET 10-K
Financial Results BrightView Holdings, Inc. BV

BrightView Holdings FY 2026 Results: Net Income $1M, Down 98.2% YoY

BrightView Holdings, Inc. faces risks from macroeconomic volatility, including inflation, potential recession, and supply chain disruptions affecting raw material costs like fuel and fertilizer. The company notes that economic downturns may lead customers to reduce spending on landscape services or perform maintenance in-house.

Key figure
Net income $1M · -98.2% YoY
4:13 PM ET 10-Q
Financial Results 21Shares XRP ETF TOXR

21Shares XRP ETF Q3 2026 Results: Net Income $47.8M, Down 12.6% YoY

The 21Shares XRP ETF reported a net asset value of $159.7 million as of September 30, 2026, down from $247.7 million at year-end 2025. The Trust experienced a net decrease in net assets resulting from operations of $37.4 million for the nine months ended September 30, 2026, primarily driven by unrealized depreciation on its XRP holdings and cash redemptions.

Key figure
Net income $47.8M · -12.6% YoY
4:13 PM ET 8-K
Financial Results GrowGeneration Corp. GRWG

GrowGeneration Financial Results

GrowGeneration reported Q3 2026 financial results, achieving positive GAAP net income of $0.2 million and expanding gross margins to 32.4%. The company also announced a 2026 Restructuring Plan involving the closure of 4-5 underperforming retail locations and workforce reductions to focus on its proprietary-brand business. Full-year 2026 revenue guidance was narrowed to a range of $163 million to $165 million.

Term
Q3 2026

“Our third-quarter results reflect the continued progress of GrowGeneration's transformation into a national commercial cultivation supply and proprietary-brand platform. We delivered $44.8 million in revenue, expanded gross margin to 32.4%, and generated $2.3 million in Adjusted EBITDA.”

Darren Lampert, GrowGen’s Co-Founder and Chief Executive Officer

“We are also continuing to take meaningful actions to improve our cost structure, including a strategic restructuring plan initiated in the fourth quarter. Store and other operating expenses declined approximately 12% year-over-year, and we are moving forward with four to five store closures in the fourth quarter, along with additional restructuring initiatives designed to further reduce fixed costs and improve operating efficiency.”

Darren Lampert, GrowGen’s Co-Founder and Chief Executive Officer
4:13 PM ET 8-K
Financial Results Alto Neuroscience, Inc. ANRO

Alto Neuroscience Financial Results

Alto Neuroscience reported financial results for the third quarter ended September 30, 2026, highlighting a cash position of $319.8 million following a $100 million financing. The company confirmed its clinical pipeline remains on track, with topline data for its PACE-1 trial in treatment-resistant depression expected in the second half of 2027.

“During the third quarter, we continued to advance our clinical programs and strengthened our financial position ahead of a milestone-rich 2027. PACE-1 remains on track, and our recent financing has enabled us to expand the ALTO-207 Phase 3 development plans to include both monotherapy and adjunctive trials, aimed at supporting a broad label in TRD.”

Amit Etkin, M.D., Ph.D., founder and chief executive officer
4:12 PM ET 10-Q
Financial Results Context Therapeutics Inc. CNTX

Context Therapeutics Q3 2026 Results: Net Loss of $7.62M, Loss Narrows

Context Therapeutics Inc. is a clinical-stage biopharmaceutical company focusing on the development of CTIM-76 and CT-202, while winding down its CT-95 Phase 1 clinical trial. As of November 6, 2026, the company had 91,879,177 shares of common stock outstanding and is classified as a smaller reporting company and emerging growth company.

Key figure
Net loss $7.62M
4:12 PM ET 10-Q
Financial Results Bluerock Homes Trust, Inc. BHM

Bluerock Homes Trust Q3 2026 Results: Net Loss of $8.48M, Loss Narrows

Bluerock Homes Trust reported a net loss of $8.48 million for the third quarter of 2026, with total revenues increasing to $19.20 million compared to $16.61 million in the prior year period. The company's total assets stood at $1.17 billion as of September 30, 2026, while it continued to experience net losses attributable to common stockholders of $3.14 million for the quarter.

Key figure
Net loss $8.48M
4:12 PM ET 8-K
Financial Results Resideo Technologies, Inc. REZI

Resideo Technologies Financial Results

Resideo Technologies reported Q3 2026 financial results, its first quarter following the spin-off of its ADI Global Distribution business. The company achieved 3% revenue growth to $727 million and used a $900 million dividend from the ADI separation plus cash on hand to repay $1.1 billion in gross debt.

Term
Q3 2026

“Resideo delivered top and bottom line third quarter results that were near the high end of our outlook ranges in our first quarter following the separation of ADI, underscoring our team’s continued strong execution. We achieved 3% revenue growth year-over-year across all sales channels and 6% growth year-over-year excluding OEM Security, driven by customer demand for our differentiated, non-discretionary products.”

Tom Surran, Resideo's President and CEO

“We remain focused on creating value for our customers with our differentiated products and services. That includes new AI-powered capabilities on our next-generation FORTIQ software platform, which delivers actionable intelligence that enhances customer productivity and optimizes the end-user’s experience.”

Tom Surran, Resideo's President and CEO
4:12 PM ET 8-K
Financial Results Kopin Corp KOPN

Kopin Financial Results

Kopin Corporation reported Q3 2026 financial results with revenue growing 52% year-over-year to $18.2 million. The company narrowed its operating loss to $0.5 million and highlighted a significant $18.6 million U.S. Army IBAS award for its MicroLED technology.

Term
Q3 2026
4:12 PM ET 10-Q
Financial Results Cohen & Steers Income Opportunities REIT, Inc. CNSREIT

Cohen & Steers Income Opportunities REIT Q3 2026 Results: Net Loss of $6.49M, Loss Widens

For the nine months ended September 30, 2026, the REIT reported a net loss of $5.1 million on total revenues of $43.0 million, compared to a net loss of $68,000 on $23.6 million in revenue for the same period in 2025. Total assets grew significantly to $866.4 million from $514.4 million at year-end 2025, driven by increased investments in real estate and real estate-related securities.

Key figure
Net loss $6.49M
4:12 PM ET 10-Q
Financial Results EQT Exeter Real Estate Income Trust, Inc.

EQT Exeter Real Estate Income Trust Q3 2026 Results: Net Loss of $449K, Loss Widens

For the nine months ended September 30, 2026, EQT Exeter Real Estate Income Trust reported total revenues of $31.0 million and a net loss of $1.5 million. Total assets increased to $557.8 million from $541.3 million at year-end 2025, while the company continued to issue multiple classes of common stock to fund its real estate investment activities.

Key figure
Net loss $449K
4:12 PM ET 10-Q
Financial Results Revvity, Inc. RVTY

Revvity Q3 2026 Results: Net Income $62.3M, Up 33.5% YoY

Revvity, Inc. reported total revenue of $728.9 million for the third quarter of 2026, a 4% increase compared to the same period in 2025. Net income for the quarter rose to $62.3 million, up from $46.7 million year-over-year, while the company continued to execute its share repurchase program, reducing outstanding common stock to approximately 111.6 million shares.

Key figure
Net income $62.3M · +33.5% YoY
4:12 PM ET 10-Q
Financial Results Achieve Life Sciences, Inc. QUIT

Achieve Life Sciences Q3 2026 Results: Net Loss of $12.1M, Loss Narrows

Achieve Life Sciences significantly strengthened its liquidity position, ending September 30, 2026, with $201.5 million in cash and marketable securities compared to $36.4 million at the end of 2025. The company is focused on its NDA resubmission for cytisinicline following a CRL and is currently involved in arbitration with its supplier, Sopharma.

Key figure
Net loss $12.1M
4:11 PM ET 10-Q
Financial Results Velo3D, Inc. VELO ▶ Call

Velo3D Q3 2026 Results: Net Loss of $16.7M, Loss Widens

Velo3D, Inc. reported a significant increase in total assets to $252.3 million as of September 30, 2026, driven by a rise in cash and cash equivalents to $75.7 million and a substantial increase in other assets. The company continues to focus on scaling its additive manufacturing solutions, particularly in the defense and aerospace markets, while managing its liquidity and debt obligations.

Key figure
Net loss $16.7M
4:11 PM ET 10-Q
Financial Results Chain Bridge Bancorp Inc CBNA

Chain Bridge Bancorp Q3 2026 Results: Net Income $10.9M, Up 132.3% YoY

Chain Bridge Bancorp, Inc. is a bank holding company for Chain Bridge Bank, N.A., specializing in services for political organizations. The filing highlights risks related to deposit seasonality following the November 2026 elections and the company's dual-class stock structure controlled by the Fitzgerald Family.

Key figure
Net income $10.9M · +132.3% YoY
4:11 PM ET 10-Q
Financial Results Bionano Genomics, Inc. BNGO ▶ Call

Bionano Genomics Q3 2026 Results: Net Loss of $6.45M, Loss Narrows

Bionano Genomics reported total revenue of $8.28 million for the third quarter of 2026, a 12% increase year-over-year, while narrowing its quarterly net loss to $6.45 million compared to $8.50 million in 2025. The company's cash position remains tight, with total cash, cash equivalents, and investments decreasing significantly from $19.27 million at the end of 2025 to $8.17 million as of September 30, 2026.

Key figure
Net loss $6.45M
4:11 PM ET 10-Q
Financial Results Electromed, Inc. ELMD

Electromed Q1 2026 Results: Net Income $2.76M, Up 29.3% YoY

Electromed, Inc. reported net revenues of $18.7 million for the quarter ended September 30, 2026, a 10.6% increase over the prior year, driven primarily by growth in the homecare market. Net income rose to $2.8 million from $2.1 million, while the company significantly increased its common stock repurchases to $4.3 million during the period.

Key figure
Net income $2.76M · +29.3% YoY
4:11 PM ET 10-Q
Financial Results Carlsmed, Inc. CARL

Carlsmed Q3 2026 Results: Net Loss of $12.2M, Loss Widens

Carlsmed, Inc. reported revenue of $56.6 million for the nine months ended September 30, 2026, a significant increase from $35.3 million in the prior year period. Despite the revenue growth, the company recorded a net loss of $31.5 million for the first nine months of 2026 as operating expenses, particularly in sales, marketing, and general administration, increased substantially.

Key figure
Net loss $12.2M
4:11 PM ET 10-Q
Financial Results Kura Oncology, Inc. KURA

Kura Oncology Q3 2026 Results: Net Loss of $70.2M, Loss Narrows

Kura Oncology reported total revenue of $22.8 million for Q3 2026, driven by the introduction of $13.9 million in product revenue. Despite this, the company recorded a net loss of $70.2 million for the quarter and $211.9 million for the first nine months of 2026, with total stockholders' equity declining significantly to $18.0 million from $174.1 million at year-end 2025.

Key figure
Net loss $70.2M
4:11 PM ET 8-K
Financial Results Atara Biotherapeutics, Inc. ATRA

Atara Biotherapeutics Financial Results

Atara Biotherapeutics reported Q3 2026 financial results, highlighting a significant 83% year-over-year reduction in operating expenses and a net loss of $2.2 million. The company is focused on the FDA's March 31, 2027, PDUFA date for tab-cel, which if approved would trigger a $31 million milestone payment from Pierre Fabre Laboratories.

“The resubmission of the tab-cel BLA was an important milestone this quarter, and we remain focused on supporting Pierre Fabre Pharmaceuticals (PFP) toward a successful outcome. We continue to believe in tab-cel’s significant commercial potential in the U.S. In parallel, we are taking steps to control expenses with the goal of protecting and maximizing shareholder value while enhancing our strategic flexibility.”

Cokey Nguyen, President and Chief Executive Officer
4:11 PM ET 8-K
Financial Results Intelligent Protection Management Corp. IPM

Intelligent Protection Management Financial Results

Intelligent Protection Management Corp. reported Q3 2026 revenue of $11.0 million, a 75% increase year-over-year, driven by strong demand for cybersecurity and cloud infrastructure procurement. The company generated $5.6 million in operating cash flow and noted a 33% increase in core managed services revenue from non-affiliated customers.

Term
Q3 2026

“Financial results for the third quarter of 2026 reflected exceptional customer demand and continued execution of our growth strategy, resulting in total revenue increasing more than 75% to approximately $11.0 million compared to the third quarter of 2025.”

Jason Katz, Chairman and Chief Executive Officer

“Our balance sheet remains strong, providing the financial flexibility necessary to support organic growth initiatives while pursuing strategic opportunities that enhance our long-term growth profile.”

Jason Katz, Chairman and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.